Lakefront Biotherapeutics N.V.
LKFT | NASDAQ
$31.97
-$0.31 (-0.96%)
Nov 2, 2026, 12:09 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 990.58M | 1.04B | 1.11B | 286.92M | 275.61M | 288.19M | 275.65M | -8.97M | 51.21M | 33.39M | 29.53M | 328.76M | 344.94M | 422.49M | 500.27M | 577.15M | 505.14M | 367.53M | 231.18M | 64.19M |
Cost of Revenue | 50.74M | 20.81M | 29.74M | 142.21M | 224.43M | 309.89M | 34.86M | 6.36M | 231.18M | 197.19M | 511.05M | 451.11M | 250.17M | 229.73M | 280.01M | 370.17M | 362.95M | 327.21M | 224.38M | 109.73M |
Gross Profit | 939.84M | 1.02B | 1.08B | 144.71M | 51.18M | -21.7M | 240.79M | 153.52M | -11.12M | 5.05M | -312.66M | -122.35M | 94.77M | 195.31M | 222.81M | 209.53M | 144.74M | 40.32M | 6.8M | -45.53M |
Operating Income | 609.93M | 596.4M | 501.39M | -338.46M | -351.09M | -332.24M | -206.67M | -194.93M | -170.86M | -146.18M | -166.23M | -92.92M | -100.27M | -163.09M | -131.06M | -124.91M | -165.53M | -89.19M | -68.05M | -78.2M |
Interest Income | 25.69M | 23.51M | 22.52M | 41.2M | 61.68M | 76.09M | 88.47M | 97.47M | 94.04M | 103.3M | 78.36M | 58.57M | 45.42M | 11.8M | 11.8M | 3.9M | n/a | n/a | n/a | n/a |
Pretax Income | 577.66M | 471.19M | 300.87M | -462.68M | -290.33M | -181.81M | -2.51M | -84.14M | -9.27M | 3.43M | -67.4M | -68.67M | -72.15M | -107.15M | -70.85M | 11.54M | -75.17M | -56.95M | -45.37M | -64.46M |
Net Income | 596.64M | 488.78M | 320.88M | -435.96M | -284.27M | -169.54M | 74.08M | 206.33M | 282.59M | 278.71M | 211.7M | -153.07M | -157.35M | -181.47M | -217.99M | 5.57M | -80.6M | -61.57M | -48.26M | -64.61M |
Selling & General & Admin | 107.75M | 103.67M | 111.96M | 149.02M | 131.86M | 146.2M | 133.5M | 144.85M | 176.16M | 173.91M | 169.51M | 200.48M | 208.58M | 247.34M | 282.99M | 260.24M | 237.01M | 167.36M | 105.02M | 45.45M |
Research & Development | 237.89M | 307.63M | 459.42M | 449.1M | 468.26M | 446.6M | 336.17M | 309.87M | 317.13M | 299.7M | 279.23M | 333.57M | 347.82M | 414.3M | 462.36M | 450.82M | 445.46M | 322.8M | 222.88M | 109.2M |
Other Expenses | -15.72M | 15.25M | 9.74M | -133.28M | -216.18M | -300.58M | -40.55M | -275.12M | -502.4M | -491.23M | -803M | -456.52M | -254.41M | -260.37M | -309.64M | -440.72M | -436.3M | -360.65M | -253.05M | -121.98M |
Operating Expenses | 329.92M | 426.55M | 581.12M | 464.84M | 383.94M | 292.22M | 429.12M | 179.6M | -9.12M | -17.62M | -354.27M | 77.53M | 301.99M | 401.26M | 435.71M | 270.34M | 246.17M | 129.51M | 74.85M | 32.67M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 844K | 844K | 844K | 1.43M | 588K | 3.06M | 6.4M | 5.81M | 5.81M | 3.34M |
Selling & Marketing Expenses | 6.41M | -12K | 1.39M | 11.42M | 10.62M | 18.46M | 17.19M | 92.65M | 119.45M | 115.68M | 113.79M | 133.15M | 137.57M | 179.18M | 207.15M | 128.65M | 112M | 69.98M | 41M | 17.66M |
Cost & Expenses | 380.66M | 447.36M | 610.86M | 607.05M | 608.37M | 602.11M | 463.99M | 185.96M | 222.06M | 179.57M | 156.78M | 123.68M | 147.2M | 287.58M | 372.31M | 702.05M | 670.67M | 456.72M | 299.23M | 142.39M |
Income Tax Expense | -16.63M | -16.74M | -18.62M | -19.38M | -2.45M | -3.04M | -1.8M | -4.24M | -4.27M | 9.22M | 9.61M | 9.48M | 10.77M | -1.33M | 572K | 5.97M | 5.43M | 4.62M | 2.9M | 157K |
Shares Outstanding (Basic) | 73.71M | 65.87M | 65.9M | 65.9M | 65.9M | 65.84M | 87.39M | 68.14M | 127.11M | 252.79M | 178.94M | 66.27M | 86.23M | 137.45M | 223.76M | 65.83M | 64.91M | 66.55M | 65.41M | 65.53M |
Shares Outstanding (Diluted) | 66.93M | 65.87M | 65.9M | 65.9M | 65.9M | 65.84M | 29.84K | 65.94M | 66.24M | 65.85M | -88.95K | 66.27M | 65.62M | 66.31M | -64.45K | 65.83M | 64.91M | 66.55M | 65.41M | 65.53M |
EPS (Basic) | 9.05 | 7.42 | 4.87 | -6.71 | -4.38 | -2.71 | -0.02 | -1.19 | -0.06 | -0.07 | -0.60 | -0.64 | -0.70 | -1.05 | -1.08 | 0.09 | -1.23 | -0.94 | -0.74 | -0.99 |
EPS (Diluted) | 9.05 | 7.42 | 4.87 | -6.71 | -4.38 | -2.71 | -0.02 | -1.19 | -0.06 | -0.07 | -0.60 | -0.65 | -0.71 | -1.06 | -1.09 | 0.09 | -1.23 | -0.94 | -0.74 | -0.99 |
EBITDA | 541.6M | 475.75M | 303.09M | -338.46M | -402.32M | -346.78M | -231.01M | -185.01M | -151.22M | -109.87M | -76.95M | -163.28M | -167.32M | 9.48M | 3.87M | 137.49M | 99.04M | -73.53M | -57.9M | -70.14M |
EBIT | 533.37M | 475.75M | 303.09M | -338.46M | -402.32M | -346.78M | -231.01M | -216.12M | -182.34M | -150.27M | -121.53M | -197.31M | -207.23M | -54.75M | -61.69M | 90.41M | 49.79M | -89.18M | -68.03M | -78.2M |
Depreciation & Amortization | 8.22M | n/a | n/a | n/a | n/a | n/a | 5.83M | 36.95M | 36.01M | 45.3M | 43.64M | 33.09M | 39.91M | 64.23M | 65.57M | 47.08M | 49.25M | 15.65M | 10.13M | 8.05M |
Add to Watchlist
Select watchlists to add or remove LKFT